PubRank

Ketty Peris

Author PubWeight™ 69.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003 4.15
2 Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2009 2.26
3 Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer 2009 2.26
4 Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012. Eur J Cancer 2012 2.05
5 [The Nessos shirt: did Herakles die from scleroderma?]. J Dtsch Dermatol Ges 2011 2.03
6 Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007 1.72
7 MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol 2008 1.72
8 The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS One 2011 1.71
9 Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy. Arch Dermatol 2006 1.58
10 Jumping into the future using teledermoscopy. Skinmed 2003 1.41
11 EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer 2006 1.38
12 The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 2005 1.36
13 Eccrine poroma in an unusual site: a clinical and dermoscopic simulator of amelanotic melanoma. J Am Acad Dermatol 2005 1.28
14 A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet 2013 1.17
15 Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol 2012 1.12
16 The spectrum of dermatoscopic patterns in blue nevi. J Am Acad Dermatol 2011 1.11
17 MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer 2010 1.10
18 Dermoscopic changes in acral melanocytic nevi during digital follow-up. Arch Dermatol 2007 1.10
19 Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res 2006 1.05
20 Giant pilomatricoma. Am J Dermatopathol 2007 1.05
21 CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol 2004 1.04
22 MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis. Eur J Cancer 2012 0.95
23 Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development. Oncogene 2005 0.95
24 High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Rev Anticancer Ther 2006 0.93
25 Kaposi's sarcoma of the glans penis in an immunocompetent patient. Eur J Dermatol 2004 0.93
26 Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2006 0.92
27 Pyruvic acid peels for the treatment of photoaging. Dermatol Surg 2004 0.91
28 Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol 2009 0.89
29 The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006 0.89
30 Symmetric distribution of lupus erythematosus tumidus on the elbows. Eur J Dermatol 2006 0.88
31 Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R. BMC Genet 2008 0.87
32 On the interplay of telomeres, nevi and the risk of melanoma. PLoS One 2012 0.87
33 Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Eur J Dermatol 2007 0.87
34 Granulomatous mycosis fungoides responsive to gemcitabine. Eur J Dermatol 2002 0.87
35 Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk. Eur J Cancer 2009 0.84
36 Early melanomas dermoscopically characterized by reticular depigmentation. Arch Dermatol 2007 0.84
37 Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna. Arch Dermatol 2006 0.83
38 Psoriasis, Kaposi's sarcoma and Hodgkin's disease in a patient with Down's syndrome. Dermatology 2004 0.81
39 Skin cancer day in Italy: method of referral to open access clinics and tumor prevalence in the examined population. Eur J Dermatol 2003 0.81
40 A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis. Int J Dermatol 2015 0.80
41 Pathologic changes after photodynamic therapy for Basal cell carcinoma and Bowen disease: a histologic and immunohistochemical investigation. Arch Dermatol 2008 0.80
42 A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy. Clinicoecon Outcomes Res 2009 0.80
43 Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod. Dermatol Surg 2007 0.80
44 Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum Mutat 2003 0.79
45 Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res 2004 0.79
46 Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy. Arch Dermatol 2005 0.79
47 Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity. J Am Acad Dermatol 2013 0.79
48 Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients. J Dermatolog Treat 2013 0.79
49 Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population. BMC Public Health 2007 0.78
50 Short contact therapy with tazarotene in psoriasis vulgaris. Dermatology 2006 0.78
51 Sequential dermoscopic evolution of pigmented Spitz nevus in childhood. J Am Acad Dermatol 2003 0.78
52 Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. Eur J Cancer Prev 2012 0.77
53 Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. J Dermatolog Treat 2007 0.77
54 Efficacy evaluation of an oil-in-water emulsion (Dermoflan) in atopic dermatitis. Acta Derm Venereol 2002 0.77
55 Diagnosis and categorization of acral melanocytic lesions using teledermoscopy. J Telemed Telecare 2004 0.77
56 Rapid response of scalp psoriasis to ustekinumab. Eur J Dermatol 2012 0.77
57 Effective control of psoriasis by etanercept in a patient with HCV-related diseases. Eur J Dermatol 2008 0.77
58 Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid. J Am Acad Dermatol 2013 0.77
59 Efficacy and tolerability of 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in wrinkle reduction of photodamaged skin. J Dermatolog Treat 2011 0.76
60 Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy. Int J Hematol 2008 0.76
61 Dermoscopic evolution of a congenital combined nevus in childhood. Dermatol Surg 2005 0.76
62 HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients. Pharmacogenet Genomics 2016 0.75
63 Carcinoma cuniculatum. CMAJ 2007 0.75
64 Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream. Eur J Dermatol 2003 0.75
65 Efalizumab-induced immune thrombocytopenia during retreatment. J Am Acad Dermatol 2008 0.75
66 What is your call?: pruritic, serpiginous eruption in a returning traveller. CMAJ 2008 0.75
67 MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair. BMC Med Genet 2012 0.75
68 Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial. Arch Drug Inf 2009 0.75
69 Hypoepiluminescence microscopy of pigmented skin lesions: new approach to improve recognition of dermoscopic structures. Dermatol Surg 2006 0.75
70 Lessons on dermoscopy. Dermatol Surg 2002 0.75
71 Immunopathogenesis of psoriasis: a possible role of TGFbeta/Smads pathway. Ital J Anat Embryol 2014 0.75
72 Widespread recurrent lichenoid papular eruption--quiz case. Arch Dermatol 2004 0.75
73 Characterization of melanoma susceptibility genes in high-risk patients from Central Italy. Melanoma Res 2017 0.75
74 Treatment of lentigo maligna with tazarotene 0.1% gel. J Am Acad Dermatol 2004 0.75
75 Digitate hyperkeratosis. J Dtsch Dermatol Ges 2011 0.75
76 Dermoscopic features of thick melanoma. Dermatol Surg 2002 0.75
77 A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity. Acta Derm Venereol 2017 0.75
78 No evidence for linkage with melanoma in Italian melanoma-prone families. Cancer Epidemiol Biomarkers Prev 2008 0.75
79 Blue-whitish veil-like structure as the primary dermoscopic feature of combined nevus. Dermatol Surg 2006 0.75
80 Untreated Psoriasis Impairs Male Fertility: A Case-Control Study. Dermatology 2017 0.75
81 Effectiveness of imiquimod on Molluscum contagiosum viral chemokines. J Cutan Med Surg 2007 0.75
82 False-Negative Cases on Confocal Microscopy Examination: A Retrospective Evaluation and Critical Reappraisal. Dermatology 2016 0.75
83 The Italian Euromelanoma Day: evaluation of results and implications for future prevention campaigns. Int J Dermatol 2012 0.75
84 Giant dermatofibroma appearing during pregnancy. Acta Derm Venereol 2006 0.75
85 Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene. Acta Derm Venereol 2005 0.75
86 Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult females. Dermatol Surg 2003 0.75
87 A 72-year-old woman with papules and nodules at the site of previous mastectomy. Arch Pathol Lab Med 2005 0.75
88 Pigmented Spitz nevi. Dermatol Surg 2002 0.75
89 Lessons on dermoscopy. Dermatol Surg 2002 0.75
90 Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines. G Ital Dermatol Venereol 2015 0.75
91 Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management. Acta Derm Venereol 2017 0.75
92 Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin Type. J Drugs Dermatol 2016 0.75
93 Dermoscopic evolution of vascular pattern in two cases of amelanotic melanoma. Acta Derm Venereol 2010 0.75
94 Persistent CD20-negative primary cutaneous marginal zone lymphoma after treatment with intralesional rituximab therapy. J Am Acad Dermatol 2008 0.75
95 Cutaneous amelanotic melanoma metastasis and dermatofibromas showing a dotted vascular pattern. Acta Derm Venereol 2004 0.75
96 The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative. Int J Dermatol 2014 0.75
97 Unusual clinical and dermoscopic features in two cases of pigmented basal cell carcinoma. J Am Acad Dermatol 2005 0.75
98 Mesalazine-induced psoriasis in patients with inflammatory bowel diseases. Eur J Dermatol 2011 0.75